ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine

Yang, Hua-Yi; Liu, Mengnan; Luo, Pei*; Yao, Xin-Sheng*; Zhou, Hua*广东省人民医院; 广州中医药大学
PHYTOMEDICINE2022-9DOI: 10.1016/j.phymed.2022.154268
24被引13阅读
引用收藏
分享

摘要

Background: The field of network pharmacology showed significant development. The concept of network pharmacology has many similarities to the philosophy of traditional Chinese medicine (TCM), making it suitable to understand the action mechanisms of TCM in treating complex diseases, such as ischemic heart diseases (IHDs). @@@ Purpose: This review summarizes the representative applications of network pharmacology in deciphering the mechanism underlying the treatment of IHDs with TCM. @@@ Methods: In this report, we used "ischemic heart disease" OR "coronary heart disease" OR "coronary artery disease" OR "myocardial ischemia" AND ("network pharmacology" OR "systematic pharmacology") as keywords to search for publications from PubMed, the Web of Science, and Google Scholar databases and then analyzed the representative research reports that summarized and validated the active components and targets network of TCM in improving IHDs to show the advantages and deficiencies of network pharmacology applied in TCM research. @@@ Results: The network pharmacology research indicated that HGF, PGF, MMP3, INSR, PI3K, MAPK1, SRC, VEGF, VEGFR-1, NO, eNOS, NO3, IL-6, TNF-alpha, and more are the main targets of TCM. Apigenin, 255-macrostemonoside P, ginsenosides Re, Rb3, Rg3, SheXiang XinTongNing, colchicine, dried ginger-aconite decoction, Suxiao Xintong dropping pills, Ginseng-Danshen drug pair and Shenlian and more are the active ingredients, extracts, and formulations of TCM to ameliorate IHDs. These active compounds, extract, and formulations of TCM treat IHDs by delaying ventricular remodeling, reducing myocardial fibrosis, decreasing reactive oxygen species, regulating myocardial energy metabolism, ameliorating inflammation, mitigating apoptosis, and many other aspects. @@@ Conclusions: The network pharmacology supplies a novel research exemplification for understanding the treatment of IHDs with TCM. However, the application of network pharmacology in TCM studies is still at a superficial level. By rational combining artificial intelligence technology and network pharmacology, molecular biology, metabolomics, and other advanced theories and technologies, and systematically studying the metabolic process and the network among products, targets, and pathways of TCM from the clinical perspective may be a potential development trend in network pharmacology.

学科与关键词

关键词
Network pharmacologyIschemic heart diseasesTraditional Chinese medicineMyocardial ischemiaDatabase
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PHYTOMEDICINE
发表日期
2022-09
卷期
第 104 卷
页码
154268
DOI
10.1016/j.phymed.2022.154268
语言
GERMAN
期刊等级
2区
成果收录
SCIE
资助标注
National Key Research and Devel-opment Program of China [2017YFE0119900]; Sci-ence and Technology Development Fund, Macao SAR [0001/2020/AKP, 0053/2020/A, 0061/2019/AGJ, 0027/2017/AMJ]

作者

  • Y

    Yang, Hua-Yi (第一作者)

  • L

    Liu, Mengnan

查看全部 5 位作者收起作者
  • L

    Luo, Pei (通讯)

  • Y

    Yao, Xin-Sheng (通讯)

  • Z

    Zhou, Hua (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417